» Authors » Hans E Kaiser

Hans E Kaiser

Explore the profile of Hans E Kaiser including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 20
Citations 130
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Nasir A, Kaiser H, Boulware D, Hakam A, Zhao H, Yeatman T, et al.
Clin Colorectal Cancer . 2004 Mar; 3(4):243-7. PMID: 15025797
Cyclooxygenase-2 (COX-2) has been identified as a potential target for prevention and therapy of human colorectal cancers (CRC) and other cancers. Because right-sided colon cancers (RSCCs) exhibit clinicopathologic and genetic...
12.
Bodey B, Siegel S, Kaiser H
In Vivo . 2004 Mar; 18(1):81-100. PMID: 15011756
Dendritic cells (DCs) are present in essentially every mammalian tissue, where they operate at the interface of innate and acquired immunity by recognizing pathogens and presenting pathogen-derived peptides to T...
13.
Naidu K, Nasir A, Pinkas H, Kaiser H, Brady P, Coppola D
In Vivo . 2003 Nov; 17(5):479-82. PMID: 14598612
Glutathione-S-transferase (GST) isoenzymes are involved in the conjugation of glutathione to electrophilic carcinogens. Recent studies have shown increased levels and activities of GST in different tumors suggesting their role in...
14.
Sekharam M, Nasir A, Kaiser H, Coppola D
Anticancer Res . 2003 Jun; 23(2B):1517-24. PMID: 12820418
Colorectal carcinomas have been found to express increased levels of IGF1 and IGF1-R, as compared to normal or adenomatous colonic mucosa, and it has been postulated that a subset of...
15.
Bodey B, Siegel S, Kaiser H
In Vivo . 2002 Dec; 16(6):583-8. PMID: 12494904
During the last decade, the aberrant expression of normal testicular proteins in neoplastically transformed cells became common knowledge. Cancer/testis-antigens (CTAs) represent a novel family of immunogenic proteins. The MAGE genes...
16.
Nagorsen D, Marincola F, Kaiser H
In Vivo . 2002 Dec; 16(6):551-6. PMID: 12494900
The development of specific immunotherapeutic approaches to cancer treatment is making progress. However, a crucial clinical break-through in cancer vaccination is still missing. Spontaneous clinical remissions of malignancies are a...
17.
Lincoln D, Kaiser H, Abul H
In Vivo . 2002 Dec; 16(6):479-92. PMID: 12494892
Under appropriate nutrient agar culture conditions, primary or xenografted human and animal tumour biopsy-derived cell suspensions will form two types of colony. The first type, consisting of tight colonies of...
18.
Kaiser H, Bodey V, Siegel S, Bodey B
In Vivo . 2002 Dec; 16(6):417-22. PMID: 12494884
The purpose of this brief review is to inform the reader of the appearance of childhood neoplasms along racial and ethnic lines. The Lag time, general aspects and specific tumors,...
19.
Minev B, Guo F, Gueorguieva I, Kaiser H
In Vivo . 2002 Dec; 16(6):405-15. PMID: 12494883
This review summarizes the most recent findings and the newest approaches in the design of vaccines for breast cancer and prostate cancer. The antigens associated with breast cancer and prostate...
20.
Bodey B, Siegel S, Kaiser H
In Vivo . 2002 Jun; 16(2):127-40. PMID: 12073772
Mammalian thymic histogenesis can be morphologically divided into three consecutive stages: 1) epithelial; 2) lymphopoietic or lympho-epithelial; and 3) differentiated cellular microenvironmental, with formation of Hassall's bodies (HBs). The marked...